A phase I study of moxetumomab pasudotox in adults with relapsed or refractory B-cell acute lymphoblastic leukaemia
- Nicholas J. Short,
- Hagop Kantarjian,
- Elias Jabbour,
- ,
- Deborah A. Thomas,
- Michael E. Rytting
- University of Texas MD Anderson Cancer Center
Scholary Output:
Contribution to journal
Letter
Peer-review
Open access
Publication Information
Output type
Scholary Output:
Contribution to journal
Letter
Peer-reviewOriginal language
English (US)Pages from-to (Number of pages)
Pages 442-444 (3 pages)Journal (Volume, Issue Number)
British Journal of Haematology (Volume 182, Issue 3)Publication milestones
- Published - 08/2018
Publication status
Published - 08/2018
ISSN
0007-1048Publication IDs
- Scopus: 85020737884
- PubMed: 28616864
- ORCID: /0000-0002-8636-1071/work/68888085
Publication metrics
Metrics
SciVal
citations
4
SciVal
FWCI
0.97
SciVal
Author count
16
SciVal
Paper percentile
62
Fractional count
1
Fractional count
0.06
Fractional count
15
Fractional count
0.94
Fractional count
1
Fractional count
1
PlumX, opens in new tab
Citation count
13
Captures
20
Funding Details
Supported by Medimmune and the MD Anderson Cancer Center Support Grant CA016672.
FundersFunding numbers
NCI
K12CA088084
MD Anderson Cancer Center
CA016672